Fig. 3: Prevalence of late cytopenias after CAR T-cell infusion. | Bone Marrow Transplantation

Fig. 3: Prevalence of late cytopenias after CAR T-cell infusion.

From: Effect of early granulocyte-colony-stimulating factor administration in the prevention of febrile neutropenia and impact on toxicity and efficacy of anti-CD19 CAR-T in patients with relapsed/refractory B-cell lymphoma

Fig. 3

Sunburst chart showing the overlapping prevalence of neutropenia, thrombocytopenia, and anemia across at day 30 (a) and day 90 (b) post–CAR T infusion. Concentric rings are organized in a hierarchical structure outward from the origin, with overlapping segments representing shared cytopenias within the same patient(s); the numbers shown in each outer ring segment represent patient(s) with that unique combination of cytopenias. The prevalence of individual cytopenias are shown in the accompanying keys.

Back to article page